Literature DB >> 22399347

Notch signaling in cancer stem cells.

Jialiang Wang1, Bruce A Sullenger, Jeremy N Rich.   

Abstract

Subpopulations of cancer cells with stem cell-like characteristics, termed cancer stem cells, have been identified in a wide range of human cancers. Cancer stem cells are defined by their ability to self-renew as well as recapitulate the original heterogeneity of cancer cells in culture and in serial xenotransplants. Not only are cancer stem cells highly tumorigenic, but these cells are implicated in tumor resistance to conventional chemotherapy and radiotherapy, thus highlighting their significance as therapeutic targets. Considerable similarities have been found between cancer stem cells and normal stem cells on their dependence on certain signaling pathways. More specifically, the core stem cell signaling pathways, such as the Wnt, Notch and Hedgehog pathways, also critically regulate the self-renewal and survival of cancer stem cells. While the oncogenic functions of Notch pathway have been well documented, its role in cancer stem cells is just emerging. In this chapter, we will discuss recent advances in cancer stem cell research and highlight the therapeutic potential of targeting Notch in cancer stem cells.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22399347     DOI: 10.1007/978-1-4614-0899-4_13

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  43 in total

Review 1.  Cancer chemoprevention with dietary isothiocyanates mature for clinical translational research.

Authors:  Shivendra V Singh; Kamayani Singh
Journal:  Carcinogenesis       Date:  2012-06-27       Impact factor: 4.944

2.  HMMR maintains the stemness and tumorigenicity of glioblastoma stem-like cells.

Authors:  Jessica Tilghman; Hao Wu; Yingying Sang; Xiaohai Shi; Hugo Guerrero-Cazares; Alfredo Quinones-Hinojosa; Charles G Eberhart; John Laterra; Mingyao Ying
Journal:  Cancer Res       Date:  2014-04-07       Impact factor: 12.701

Review 3.  T memory stem cells and HIV: a long-term relationship.

Authors:  Ann Chahroudi; Guido Silvestri; Mathias Lichterfeld
Journal:  Curr HIV/AIDS Rep       Date:  2015-03       Impact factor: 5.071

4.  Sustained activation of notch signaling maintains tumor-initiating cells in a murine model of liposarcoma.

Authors:  Pei-Chieh Tien; Menchus Quan; Shihuan Kuang
Journal:  Cancer Lett       Date:  2020-08-28       Impact factor: 8.679

5.  The Small Molecule IMR-1 Inhibits the Notch Transcriptional Activation Complex to Suppress Tumorigenesis.

Authors:  Luisana Astudillo; Thiago G Da Silva; Zhiqiang Wang; Xiaoqing Han; Ke Jin; Jeffrey VanWye; Xiaoxia Zhu; Kelly Weaver; Taiji Oashi; Pedro E M Lopes; Darren Orton; Leif R Neitzel; Ethan Lee; Ralf Landgraf; David J Robbins; Alexander D MacKerell; Anthony J Capobianco
Journal:  Cancer Res       Date:  2016-04-13       Impact factor: 12.701

6.  c-Jun N-terminal kinase promotes stem cell phenotype in triple-negative breast cancer through upregulation of Notch1 via activation of c-Jun.

Authors:  X Xie; T S Kaoud; R Edupuganti; T Zhang; T Kogawa; Y Zhao; G B Chauhan; D N Giannoukos; Y Qi; D Tripathy; J Wang; N S Gray; K N Dalby; C Bartholomeusz; N T Ueno
Journal:  Oncogene       Date:  2016-12-12       Impact factor: 9.867

Review 7.  Cancer stem cells as targets for immunotherapy.

Authors:  Amy S Codd; Takayuki Kanaseki; Toshihiko Torigo; Zsuzsanna Tabi
Journal:  Immunology       Date:  2017-12-18       Impact factor: 7.397

8.  Prolonged inhibition of glioblastoma xenograft initiation and clonogenic growth following in vivo Notch blockade.

Authors:  Qian Chu; Brent A Orr; Samantha Semenkow; Eli E Bar; Charles G Eberhart
Journal:  Clin Cancer Res       Date:  2013-04-29       Impact factor: 12.531

9.  A multi-arm phase I dose escalating study of an oral NOTCH inhibitor BMS-986115 in patients with advanced solid tumours.

Authors:  Kyaw L Aung; Anthony B El-Khoueiry; Karen Gelmon; Ben Tran; Gaurav Bajaj; Bing He; Tian Chen; Lili Zhu; Sharath Poojary; Shashwati Basak; Zhenhao Qi; Anna Spreafico; Bruce S Fischer; Jayesh Desai
Journal:  Invest New Drugs       Date:  2018-04-10       Impact factor: 3.850

10.  Honokiol as a Radiosensitizing Agent for Colorectal cancers.

Authors:  Zhiyun He; Dharmalingam Subramaniam; Zhongtao Zhang; Youcheng Zhang; Shrikant Anant
Journal:  Curr Colorectal Cancer Rep       Date:  2013-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.